FCE-27733

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameFCE-27733
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsPsychotic DisordersAnxiety DisordersVomiting +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia Corporation
Active IndicationsN/A
Inactive IndicationsPsychotic DisordersAnxiety DisordersVomiting +[4] 

Other Information

ATC CodeN/A
Related LinksN/A